Skip to main content

Table 5 Comparison of laboratory findings of acute phase reaction in three visits

From: Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial

  Once-daily dosage group (n = 42) Twice-daily dosage group (n = 37)  
Baseline First visit Second visit Baseline First visit Second visit p Valuea
Leukocytosis, % 11.9 4.8 4.8 8.1 2.7 5.4 0.591
Thrombocytosis, % 4.8 2.4 4.8 5.4 2.7 10.8 0.329
High ESR, % 55.9 12.5 4.2 56.7 22.2 0 0.988
Elevated CRP, % 40.5 21.4 14.3 37.8 13.5 10.8 0.435
SAA,b mg/L 4.86 ± 3.73   3.28 ± 3.40 4.70 ± 3.57   3.28 ± 3.46 0.449
  1. CRP C-reactive protein, ESR erythrocyte sedimentation rate, SAA serum amyloid A
  2. a p value for intergroup comparison of laboratory results
  3. bMean ± SD